The estimated Net Worth of Janet Zelenka is at least $4.89 Milion dollars as of 15 March 2024. Ms Zelenka owns over 13,147 units of Stericycle stock worth over $3,433,971 and over the last 8 years she sold SRCL stock worth over $0. In addition, she makes $1,451,837 as Exec. VP a CFO & Chief Information Officer at Stericycle.
Sign up
Ms Zelenka SRCL stock SEC Form 4 insiders trading
Ms has made over 11 trades of the Stericycle stock since 2020, according to the Form 4 filled with the SEC. Most recently she exercised 13,147 units of SRCL stock worth $810,775 on 15 March 2024.
The largest trade she's ever made was exercising 18,255 units of Stericycle stock on 10 March 2023 worth over $1,125,786. On average, Ms trades about 3,316 units every 56 days since 2016. As of 15 March 2024 she still owns at least 55,683 units of Stericycle stock.
You can see the complete history of Ms Zelenka stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ms. Janet H. Zelenka biography
Janet H. Zelenka is the Exec. VP, CFO & Chief Information Officer at Stericycle.
What is the salary of Ms Zelenka?
As the Exec. VP a CFO & Chief Information Officer of Stericycle, the total compensation of Ms Zelenka at Stericycle is $1,451,837. There are 2 executives at Stericycle getting paid more, with Cindy Miller having the highest compensation of $3,215,910.
How old is Ms Zelenka?
Ms Zelenka is 62, she's been the Exec. VP a CFO & Chief Information Officer of Stericycle since . There are 6 older and 19 younger executives at Stericycle. The oldest executive at Stericycle Inc. is Veronica Hagen, 74, who is the Independent Director.
What's Ms Zelenka's mailing address?
Janet's mailing address filed with the SEC is 2355 WAUKEGAN ROAD, , BANNOCKBURN, IL, 60015.
Insiders trading at Stericycle
Over the last 21 years, insiders at Stericycle have traded over $161,740,081 worth of Stericycle stock and bought 27,280 units worth $1,574,920 . The most active insiders traders include Jack W Schuler, John Connaughton a James Reid Anderson. On average, Stericycle executives and independent directors trade stock every 23 days with the average trade being worth of $835,752. The most recent stock trade was executed by Jesse Joel Jr Hackney on 16 May 2024, trading 3,620 units of SRCL stock currently worth $223,245.
What does Stericycle do?
stericycle is a global services company. we provide highly specialized solutions serving healthcare organizations and commercial businesses of every size and shape. throughout the last 25 years, we have grown from a small start-up in medical waste management into a leader across a range of increasingly complex and highly regulated arenas, such as: • brand protection solutions • environmental & sustainable solutions • patient & customer communication solutions • regulated waste management & compliance solutions from the start we have challenged the status quo of what a business solution can be. by identifying unmet needs, we have redefined and transformed multiple industries from a narrowly defined service category to a robust suite of solutions that customers need and want. our success with this strategy has landed stericycle among the fortune 1000 list and forbes 25 most innovative companies. a publicly-traded company with $2.5 billion in 2014 revenue, our core purpose is to
What does Stericycle's logo look like?
Complete history of Ms Zelenka stock trades at Stericycle
Stericycle executives and stock owners
Stericycle executives and other stock owners filed with the SEC include:
-
Cindy Miller,
President, Chief Executive Officer, Director -
Cindy J. Miller,
Pres, CEO & Director -
Janet H. Zelenka,
Exec. VP, CFO & Chief Information Officer -
Daniel Ginnetti,
Executive Vice President - International -
Janet Zelenka,
Chief Financial Officer, Executive Vice President, Chief Information Officer -
Kurt Rogers,
Executive Vice President, General Counsel and Corporate Secretary -
Joseph Reuter,
Executive Vice President and Chief People Officer -
Stephen Cory White,
Exec. VP & Chief Commercial Officer -
Kurt M. Rogers,
Exec. VP, Gen. Counsel & Corp. Sec. -
Robert Murley,
Independent Chairman of the Board -
Brian Anderson,
Independent Director -
Lynn Bleil,
Independent Director -
Michael Zafirovski,
Independent Director -
Kay Priestly,
Independent Director -
Veronica Hagen,
Independent Director -
Thomas Chen,
Independent Director -
J. Joel Hackney,
Independent Director -
Stephen Hooley,
Independent Director -
S. Cory White,
Executive Vice President and Chief Commercial Officer -
Richard Moore,
Executive Vice President - North American Operations -
Dominic Culotta,
Executive Vice President and Chief Engineer -
Michael Weisman,
Executive Vice President, Chief Ethics and Compliance Officer -
Richard Michael Moore,
Exec. VP of North American Operations -
Joseph Anthony Reuter,
Exec. VP & Chief People Officer -
Michael S. Weisman,
Exec. VP and Chief Ethics & Compliance Officer -
Andrew Ellis,
VP of Investor Relations -
Daniel V. Ginnetti,
Exec. VP of International -
Jennifer Koenig,
VP of Corp. Communications & Investor Relations -
Richard Joseph Hoffman,
Sr. VP & Chief Accounting Officer -
Richard J Hoffman,
SVP & CHIEF ACCOUNTING OFFICER -
John P Schetz,
Sr Counsel M & A -
Thomas D Brown,
Director -
Mike S Zafirovski,
Director -
John Patience,
Director -
Jack W Schuler,
Chairman -
Brenda R Frank,
EVP & Chief People Officer -
Brent Arnold,
President, USA/Canada -
Ruth Ellen Abdulmassih,
Executive Vice President -
Rodney F Dammeyer,
Director -
Charles A Alutto,
President, USA -
Robert Guice,
Executive Vice President, Intl -
David W. Stahl,
EVP and CIO -
William J. Seward,
EVP, Chief Commercial Officer -
James Reid Anderson,
Director -
Mark C Miller,
CEO -
Michael J Collins,
President, Pharma Services -
Shan Sacranie,
Exec Vice Pres International -
Richard L Foss,
EXVP -
Richard T Kogler,
COO -
Richard J Marasco,
Exec VP Corp Mergers & Acquis -
Thomas R Reusche,
Director -
L John Wilkerson,
Director -
Jonathan T Md Lord,
Director -
Peter Vardy,
Director -
Brink Frank Jm Ten,
CFO -
William K Hall,
Director -
Ronald G Spaeth,
Director -
Patrick F Graham,
Director -
Anthony J Tomasello,
Vice President -
James J Martell,
Director -
John Connaughton,
Director -
James L Welch,
-
Victoria L Dolan,
-
Naren K Gursahaney,